Metachronous gastric adenocarcinoma following gastric lymphoma treated with chemotherapy and radiation therapy
Descripción del Articulo
Gastric cancer ranks fifth in both incidence and mortality worldwide, according to the report fromthe Global Cancer Observatory (Globocan) as of 2022 (1). When discussing the global gastric cancerreport, it is assumed that it refers to adenocarcinoma. However, it should be pointed out that themost f...
Autores: | , , , , |
---|---|
Formato: | artículo |
Fecha de Publicación: | 2025 |
Institución: | Universidad de San Martín de Porres |
Repositorio: | Horizonte médico |
Lenguaje: | español |
OAI Identifier: | oai:horizontemedico.usmp.edu.pe:article/3321 |
Enlace del recurso: | https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/3321 |
Nivel de acceso: | acceso abierto |
Materia: | Lymphoma Adenocarcinoma Stomach Neoplasms Neoplasms, Second Primary Linfoma Neoplasias Gástricas Neoplasias Primarias Secundarias |
id |
REVHM_400adee4a369b4124904215679e50286 |
---|---|
oai_identifier_str |
oai:horizontemedico.usmp.edu.pe:article/3321 |
network_acronym_str |
REVHM |
network_name_str |
Horizonte médico |
repository_id_str |
|
dc.title.none.fl_str_mv |
Metachronous gastric adenocarcinoma following gastric lymphoma treated with chemotherapy and radiation therapy Adenocarcinoma gástrico metacrónico luego de linfoma gástrico tratado con quimioterapia más radioterapia |
title |
Metachronous gastric adenocarcinoma following gastric lymphoma treated with chemotherapy and radiation therapy |
spellingShingle |
Metachronous gastric adenocarcinoma following gastric lymphoma treated with chemotherapy and radiation therapy Barreda Bolaños, Fernando Lymphoma Adenocarcinoma Stomach Neoplasms Neoplasms, Second Primary Linfoma Adenocarcinoma Neoplasias Gástricas Neoplasias Primarias Secundarias |
title_short |
Metachronous gastric adenocarcinoma following gastric lymphoma treated with chemotherapy and radiation therapy |
title_full |
Metachronous gastric adenocarcinoma following gastric lymphoma treated with chemotherapy and radiation therapy |
title_fullStr |
Metachronous gastric adenocarcinoma following gastric lymphoma treated with chemotherapy and radiation therapy |
title_full_unstemmed |
Metachronous gastric adenocarcinoma following gastric lymphoma treated with chemotherapy and radiation therapy |
title_sort |
Metachronous gastric adenocarcinoma following gastric lymphoma treated with chemotherapy and radiation therapy |
dc.creator.none.fl_str_mv |
Barreda Bolaños, Fernando Medrano Palma, Enaida Barreda Velit, Claudia Quispe Cordova, Rita Bravo Taxa, Mercedes del Pilar |
author |
Barreda Bolaños, Fernando |
author_facet |
Barreda Bolaños, Fernando Medrano Palma, Enaida Barreda Velit, Claudia Quispe Cordova, Rita Bravo Taxa, Mercedes del Pilar |
author_role |
author |
author2 |
Medrano Palma, Enaida Barreda Velit, Claudia Quispe Cordova, Rita Bravo Taxa, Mercedes del Pilar |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
Lymphoma Adenocarcinoma Stomach Neoplasms Neoplasms, Second Primary Linfoma Adenocarcinoma Neoplasias Gástricas Neoplasias Primarias Secundarias |
topic |
Lymphoma Adenocarcinoma Stomach Neoplasms Neoplasms, Second Primary Linfoma Adenocarcinoma Neoplasias Gástricas Neoplasias Primarias Secundarias |
description |
Gastric cancer ranks fifth in both incidence and mortality worldwide, according to the report fromthe Global Cancer Observatory (Globocan) as of 2022 (1). When discussing the global gastric cancerreport, it is assumed that it refers to adenocarcinoma. However, it should be pointed out that themost frequent histological types of gastric cancer are adenocarcinoma and lymphoma, the formerbeing the most frequent on average, accounting for over 95 % of all gastric neoplasms (2). In Peru, theLima Metropolitan Cancer Registry ranked gastric cancer as the third most frequent and the leadingcause of mortality for both sexes (3). On the other hand, the synchronous or metachronous diagnosisof these types of gastric cancer, such as adenocarcinoma and lymphoma, is rare. Metachronouscancer, or second primary cancer, is defined as a new tumor that occurs more than six months afterthe diagnosis of the first neoplasm, but is not caused by the dissemination or recurrence of theprevious tumor (4). For these reasons, and pertinently, we present the case report of a 57-year-oldfemale patient diagnosed with primary gastric lymphoma, treated with a combination of radiationtherapy and chemotherapy with curative intent. Thirteen years later, at the age of 70, she wasdiagnosed with gastric adenocarcinoma during a follow-up endoscopy, which was managed surgically.The case is detailed below, along with a review of the relevant literature. |
publishDate |
2025 |
dc.date.none.fl_str_mv |
2025-03-17 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/3321 10.24265/horizmed.2025.v25n1.16 |
url |
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/3321 |
identifier_str_mv |
10.24265/horizmed.2025.v25n1.16 |
dc.language.none.fl_str_mv |
spa |
language |
spa |
dc.relation.none.fl_str_mv |
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/3321/2128 https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/3321/2155 https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/3321/2180 |
dc.rights.none.fl_str_mv |
Derechos de autor 2025 Horizonte Médico (Lima) https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Derechos de autor 2025 Horizonte Médico (Lima) https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf text/xml text/html |
dc.publisher.none.fl_str_mv |
Universidad de San Martín de Porres. Facultad de Medicina Humana |
publisher.none.fl_str_mv |
Universidad de San Martín de Porres. Facultad de Medicina Humana |
dc.source.none.fl_str_mv |
Horizonte Médico (Lima); Vol. 25 No. 1 (2025): Enero-Marzo; e3321 Horizonte Médico (Lima); Vol. 25 Núm. 1 (2025): Enero-Marzo; e3321 Horizonte Médico (Lima); v. 25 n. 1 (2025): Enero-Marzo; e3321 2227-3530 1727-558X reponame:Horizonte médico instname:Universidad de San Martín de Porres instacron:USMP |
instname_str |
Universidad de San Martín de Porres |
instacron_str |
USMP |
institution |
USMP |
reponame_str |
Horizonte médico |
collection |
Horizonte médico |
repository.name.fl_str_mv |
|
repository.mail.fl_str_mv |
|
_version_ |
1841556169695428608 |
spelling |
Metachronous gastric adenocarcinoma following gastric lymphoma treated with chemotherapy and radiation therapyAdenocarcinoma gástrico metacrónico luego de linfoma gástrico tratado con quimioterapia más radioterapiaBarreda Bolaños, Fernando Medrano Palma, Enaida Barreda Velit, Claudia Quispe Cordova, Rita Bravo Taxa, Mercedes del Pilar LymphomaAdenocarcinoma Stomach Neoplasms Neoplasms, Second PrimaryLinfomaAdenocarcinomaNeoplasias GástricasNeoplasias Primarias SecundariasGastric cancer ranks fifth in both incidence and mortality worldwide, according to the report fromthe Global Cancer Observatory (Globocan) as of 2022 (1). When discussing the global gastric cancerreport, it is assumed that it refers to adenocarcinoma. However, it should be pointed out that themost frequent histological types of gastric cancer are adenocarcinoma and lymphoma, the formerbeing the most frequent on average, accounting for over 95 % of all gastric neoplasms (2). In Peru, theLima Metropolitan Cancer Registry ranked gastric cancer as the third most frequent and the leadingcause of mortality for both sexes (3). On the other hand, the synchronous or metachronous diagnosisof these types of gastric cancer, such as adenocarcinoma and lymphoma, is rare. Metachronouscancer, or second primary cancer, is defined as a new tumor that occurs more than six months afterthe diagnosis of the first neoplasm, but is not caused by the dissemination or recurrence of theprevious tumor (4). For these reasons, and pertinently, we present the case report of a 57-year-oldfemale patient diagnosed with primary gastric lymphoma, treated with a combination of radiationtherapy and chemotherapy with curative intent. Thirteen years later, at the age of 70, she wasdiagnosed with gastric adenocarcinoma during a follow-up endoscopy, which was managed surgically.The case is detailed below, along with a review of the relevant literature.El cáncer gástrico ocupa el quinto lugar tanto en incidencia como en mortandad a nivel mundial, según el reporte del Global Cancer Observatory (Globocan) al 2022 (1). Cuando se habla del reporte de cáncer gástrico a nivel internacional, se da por entendido que se refiere al adenocarcinoma; sin embargo, se debe precisar que las variedades histológicas más frecuentes del cáncer gástrico son el adenocarcinoma y el linfoma, siendo el primero el más frecuente en promedio, por encima del 95 % de las neoplasias gástricas en general (2). En el Perú, el Registro de cáncer de Lima Metropolitana ubicóal cáncer gástrico como tercero en frecuencia y como la primera causa de mortandad hablando de ambos sexos (3). Por otro lado, el diagnóstico sincrónico o metacrónico de estos tipos de cáncer gástrico, como el adenocarcinoma y el linfoma, es raro. El cáncer metacrónico, o segundo cáncer primario, se define como un tumor nuevo que ocurre más de seis meses después del diagnóstico de la primera neoplasia, pero que no es causado por una diseminación o recurrencia del tumor previo (4). Debido a estos motivos, y de forma pertinente, se presenta el reporte de caso de una paciente que presentó a los 57 años un linfoma gástrico primario, para el cual recibió tratamiento oncológico combinado de radioterapia y quimioterapia con intención curativa. Luego de 13 años, a los 70, es diagnosticada de adenocarcinoma gástrico durante un control endoscópico, el cual se manejó quirúrgicamente. Se detalla el caso a continuación, y se realiza una revisión de la literatura al respecto.Universidad de San Martín de Porres. Facultad de Medicina Humana2025-03-17info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/xmltext/htmlhttps://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/332110.24265/horizmed.2025.v25n1.16Horizonte Médico (Lima); Vol. 25 No. 1 (2025): Enero-Marzo; e3321Horizonte Médico (Lima); Vol. 25 Núm. 1 (2025): Enero-Marzo; e3321Horizonte Médico (Lima); v. 25 n. 1 (2025): Enero-Marzo; e33212227-35301727-558Xreponame:Horizonte médicoinstname:Universidad de San Martín de Porresinstacron:USMPspahttps://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/3321/2128https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/3321/2155https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/3321/2180Derechos de autor 2025 Horizonte Médico (Lima)https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:horizontemedico.usmp.edu.pe:article/33212025-03-17T20:10:26Z |
score |
13.432311 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).